Skip to main content
Fig. 2 | Diagnostic Pathology

Fig. 2

From: MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases

Fig. 2

MNDA expression in 3 subtypes of MZL cases. (A-D) A case of NMZL in the cervical lymph node (×100). The neoplastic B cells diffusely expresse CD20, MNDA, and BCL2. The surviving germinal centers have no expression of MNDA and BCL2. (E-H) A case with EMZL from the salivary gland (×100). CD20, MNDA, and BCL2 present a pattern of diffuse positivity. (I-L) A case of SMZL (×100). MNDA marks the neoplastic cells in lymphoid follicles and infiltration in red pulp

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us